HEMORRHOIDAL OINTMENT 0.5 %
ZINC SULFATE MONOHYDRATE : 0.5 % PRAMOXINE HYDROCHLORIDE : 1.0 % · DIN 02218887 · PHARMASCIENCE INC
Health Canada status: CANCELLED POST MARKET
What is HEMORRHOIDAL OINTMENT?
HEMORRHOIDAL OINTMENT 0.5 % contains ZINC SULFATE MONOHYDRATE : 0.5 % PRAMOXINE HYDROCHLORIDE : 1.0 %. It is listed in the Health Canada Drug Product Database under DIN 02218887, held by PHARMASCIENCE INC, supplied as OINTMENT for RECTAL administration. Health Canada currently lists it as cancelled post market, status dated 19-Feb-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02218887 |
|---|---|
| Brand name | HEMORRHOIDAL OINTMENT |
| Generic / active ingredient | ZINC SULFATE MONOHYDRATE : 0.5 % PRAMOXINE HYDROCHLORIDE : 1.0 % |
| Manufacturer | PHARMASCIENCE INC |
| Strength | 0.5 % |
| Dosage form | OINTMENT |
| Route of administration | RECTAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | C05AD07 PRAMOCAINE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 19-Feb-2020 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02218887 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2218887 |
| Brand name | HEMORRHOIDAL OINTMENT |
| Active ingredient / INN | ZINC SULFATE MONOHYDRATE : 0.5 % PRAMOXINE HYDROCHLORIDE : 1.0 % |
| ATC code | C05AD07 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C05 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | PHARMASCIENCE INC |
Which pack is which?
| Strength on the label | 0.5 % |
|---|---|
| Dosage form | OINTMENT |
| Route | RECTAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code C05AD07 PRAMOCAINE. 2 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ANUSOL PLUS OINTMENT | 0.5 % | OINTMENT | CHURCH & DWIGHT CANADA CORP | MARKETED | DIN 01945912 |
| ANUSOL PLUS SUPPOSITORIES | 20 MG | SUPPOSITORY | CHURCH & DWIGHT CANADA CORP | MARKETED | DIN 01945904 |
| ANODAN-PLUS | 20 MG | SUPPOSITORY | ODAN LABORATORIES LTD | APPROVED | DIN 02450801 |
| ANODAN-PLUS OINTMENT | 0.5 % | OINTMENT | ODAN LABORATORIES LTD | APPROVED | DIN 02453185 |
| HEMORRHOID OINTMENT | 0.5 % | OINTMENT | JAMP PHARMA CORPORATION | DORMANT | DIN 02251981 |
| HEMORRHOID OINTMENT | 1 % | OINTMENT | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | DIN 02229647 |
| HEMORRHOIDAL OINTMENT | 0.5 % | OINTMENT | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02248891 |
| SANDOZ ANUZINC PLUS | 10 MG | OINTMENT | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02248424 |
| TRONOTHANE PRAMOXINE HCL CRM 1% USP | 1 % | CREAM | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 01963104 |
| W15883-CS | 1 % | OINTMENT | WARNER-LAMBERT CANADA INC. | CANCELLED PRE MARKET | DIN 02240584 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.